Aleph Farms
Aleph Farms is an Israeli cellular agriculture company that develops cultivated beef products, such as steaks, by growing bovine cells in bioreactors to replicate animal tissues without raising or slaughtering livestock.[1]Founded in 2017 by Didier Toubia, Shulamit Levenberg, and Neta Lavon and headquartered in Rehovot, the firm focuses on non-genetically modified cells to produce high-quality meat alternatives aimed at enhancing food security, reducing environmental impacts of farming, and improving animal welfare.[2][3][1]
Key achievements include unveiling the world's first cultivated thin-cut steak in 2018 and the first cultivated ribeye using 3D bioprinting, followed by securing the world's initial regulatory approval for non-chicken cultivated meat from Israel's Ministry of Health in 2024, enabling limited commercial sales.[4][5][6]
The company has raised over $140 million in funding, including a $105 million Series B round backed by investors like Cargill and Migros, but has encountered substantial hurdles, such as a 30% workforce reduction in 2024 and a 73% valuation cut in ongoing financing efforts amid investor skepticism toward cultivated meat's path to cost-competitive scalability.[7][8][9][10]
Independent techno-economic analyses project potential profitability for its products at scale, with production costs reduced by 97% since 2022, though broader industry challenges like bioreactor efficiency and market acceptance persist.[11][8]